<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Hyperactivity Disorder Market Reports]]></title>
    <link>http://www.reportlinker.com/report/search/isAdwords//isCountryAdwords//theme/hyperactivity_disorder</link>
    <description><![CDATA[Reportlinker.com Lastest Hyperactivity Disorder Market Reports]]></description>
    <pubDate>Mon, 20 May 2013 12:49:02 +0000</pubDate>
    <webMaster>helpdesk@reportlinker.com</webMaster>
    <copyright>Copyright 2013, Reportlinker</copyright>
    <generator>Zend_Feed</generator>
    <language>en-us</language>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[U.S. Pharmaceutical Business]]></title>
      <link>http://www.reportlinker.com/d012565344/U-S-Pharmaceutical-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012565344/U-S-Pharmaceutical-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... Co-occurring <strong>disorders</strong> are left untreated (or if only  one <strong>disorder</strong> is treated), symptoms can become acute and  result in far-reaching complications.  These complications include risk for physical ...]]></description>
      <pubDate>Fri, 30 Sep 2011 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Pharmaceutical Market  in Japan and France]]></title>
      <link>http://www.reportlinker.com/d014198637/Pharmaceutical-Market-in-Japan-and-France.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014198637/Pharmaceutical-Market-in-Japan-and-France.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... Japan S declining birthrate identify genes relating to chemical  substance sensitivity, diseases, and  <strong>disorders</strong>    Prevention           Genetic diagnosis at birth      Specialized countermeasures ...]]></description>
      <pubDate>Fri, 31 Aug 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[U.S. Pharmaceutical Industry]]></title>
      <link>http://www.reportlinker.com/d012713964/U-S-Pharmaceutical-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012713964/U-S-Pharmaceutical-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... By disability category   Learning disability                341    Attention deficit <strong>hyperactivity</strong> <strong>disorder</strong>               234   Learning disability & adhd                144   Mobility & orthopedic ...]]></description>
      <pubDate>Wed, 30 Nov 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Pharmaceutical in The United States : Innovation and Technology Trends]]></title>
      <link>http://www.reportlinker.com/d013348239/Pharmaceutical-in-The-United-States-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013348239/Pharmaceutical-in-The-United-States-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... Amp;  w guide to colleges for students  with learning  disabilities and  attention deficit <strong>disorders</strong>, 7th   edition : a resource book for  students. Parents, and professionals.   New york: princeton ...]]></description>
      <pubDate>Sat, 30 Jun 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[U.S. Pharmaceutical Industry]]></title>
      <link>http://www.reportlinker.com/d012476106/U-S-Pharmaceutical-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012476106/U-S-Pharmaceutical-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... <Strong>hyperactivity</strong> <strong>disorder</strong>   Vanderbilt test- mild depression kp.Org/communitybenefit we build a brighter future togetherhow can healthy communitydesign improve the health of ss kp.Org/communitybenefit we build ...]]></description>
      <pubDate>Thu, 31 Mar 2011 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[U.S. Pharmaceutical Business Analysis]]></title>
      <link>http://www.reportlinker.com/d012656865/U-S-Pharmaceutical-Business-Analysis.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d012656865/U-S-Pharmaceutical-Business-Analysis.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Hiv    Alcohol use    Allergies    Alzheimer S disease    Ambulatory care (doctor visits)    American indian or alaska native health    Assault/homicide    Attention deficit <strong>hyperactivity</strong> <strong>disorder</strong>    faststats ...]]></description>
      <pubDate>Mon, 31 Oct 2011 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Mental Illness Market Analysis (mental illness, autoimmune disease) in The United States]]></title>
      <link>http://www.reportlinker.com/d013206551/Mental-Illness-Market-Analysis-mental-illness-autoimmune-disease-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013206551/Mental-Illness-Market-Analysis-mental-illness-autoimmune-disease-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... With a consumer with  a mental <strong>disorder</strong> In fact, you may know  someone with a mental <strong>disorder</strong>    Mental illnesses are medical conditions.  Just as  diabetes is a <strong>disorder</strong> of the pancreas, mental illness ...]]></description>
      <pubDate>Mon, 30 Apr 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[U.S. Pharmaceutical Industry]]></title>
      <link>http://www.reportlinker.com/d013838019/U-S-Pharmaceutical-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013838019/U-S-Pharmaceutical-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... For adhd   Behavioral therapy for adhd was associated with having co- occurring mental health <strong>disorders</strong> and adhd severity rates (%) of dietary supplements for adhd   Dietary supplements for adhd treatment ...]]></description>
      <pubDate>Sun, 30 Sep 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Anxiety Disorder Sector Overview]]></title>
      <link>http://www.reportlinker.com/d013493326/Anxiety-Disorder-Sector-Overview.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013493326/Anxiety-Disorder-Sector-Overview.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... States   Depression not related to motor state non-psychiatric impact of  anxiety <strong>disorders</strong>   Increased pd motor symptoms and signs   Increased pd motor complications   Freezing   On-off fluctuations   Dyskinesias ...]]></description>
      <pubDate>Fri, 30 Sep 2011 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[U.S. Pharmaceutical Business]]></title>
      <link>http://www.reportlinker.com/d013776702/U-S-Pharmaceutical-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013776702/U-S-Pharmaceutical-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... To chemical exposures   source:  wilson and schwarzman (2008) green chemistry: cornerstone to a sustainable california,  university of california  rising incidence of diseases/<strong>disorders</strong>  linked to chemical ...]]></description>
      <pubDate>Wed, 29 Feb 2012 23:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>
